In view of the spreading Coronavirus infection in India. Now the scientists have started a new trail to find a cure. In this series, the Drug Controller General of India has now approved the introduction of an anti-viral drug called “Favipiravir” in the country. The Council of Scientific and Industrial Research (CSIR), headed by Prime Minister Narendra Modi has decided to start its trial next week.
Dr Shekhar Mande, Director General of CSIR, said that “Favipirvir” is a drug that is already being used in many countries including India for the treatment of influenza. We hope that this medicine will help us in controlling coronavirus. He told that CSIR and another company had sought permission for the human trail to treat coronavirus through this drug. CSIR has got its permission. We are hoping that by next week we will start the trail of it.
Dr Shekhar Mande told that “Favipiravir” is a safe drug and phase-2 testing can be started directly in its trial. He told that we are hoping that its trial will be completed in a month. If the trial results are satisfactory then we will be able to provide the right medicine to fight coronavirus at a very quick and affordable price.
Drug Controller General of India has given approval for clinical trials of Favipiravir which is used in influenza in Japan, China etc & could be potentially useful against #COVID19 & a phytopharmaceutical which is an extract of a plant: CSIR Director General Shekhar Mande pic.twitter.com/fxEZy1MBqR
— ANI (@ANI) May 8, 2020